Calcium and Magnesium Metabolism During Long-Term Treatment with Thiazides

REFERENCES

• Alfrey, A. C., Miller, N. L. & Butkus, D. 1974. Evaluation of body magnesium stores. J Lab Clin Med 84, 153.
   PubMed Web of Science ®Google Scholar
• Backman, U., Danielson, B. G., Johansson, G., Ljunghall, S. & Wikström, B. 1979. Effects of therapy with bendroflumethiazide in patients with recurrent renal calcium stones. Br J Urol 51, 175.
   PubMedGoogle Scholar
• Backman, U., Danielson, B. G., Johansson, G., Ljunghall, S. & Wikström, B. 1980. Incidence and clinical importance of renal tubular defects in recurrent renal stone formers. Nephron 25, 96.
   PubMed Web of Science ®Google Scholar
• Bergström, J. 1975. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35, 609.
   PubMed Web of Science ®Google Scholar
• Bordier, P., Ryckewart, A., Gueris, J. & Rasmussen, H. 1977. On the pathogenesis of so-called idiopathic hypercalciuria. Am J Med 63, 398.
   PubMed Web of Science ®Google Scholar
• Brickman, A. S., Massry, S. G. & Coburn, J. W. 1972. Changes in serum and urinary calcium during treatment with hydrochlorothiazide. Studies on mechanisms. J Clin Invest 51, 945.
   PubMed Web of Science ®Google Scholar
• Christensson, T., Hellström, K. & Wengle, B. 1977. Hypercalcemia and primary hyperparathyroidism. Prevalence in patients receiving thiazides as detected in health screen. Arch Int Med 137, 1138.
   PubMedGoogle Scholar
• Coe, F. L. 1977. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria or no metabolic disorder. Ann Int Med 87, 404.
   PubMed Web of Science ®Google Scholar
• Coe, F. L., Canterbury, J. M., Firpo, J. J. & Reiss, E. 1973. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest 52, 134.
   PubMed Web of Science ®Google Scholar
• Danielson, B. G., Johansson, G. & Ljunghall, S. 1979. Magnesium metabolism in healthy subjects. Scand J Urol Nephrol, Suppl. 51, 49.
   Google Scholar
• Dyckner, T. & Wester, P. O. 1978. The relation between extra- and intracellular electrolytes in patients with hypokalemia and/or diuretic treatment. Acta Med Scand 204, 269.
   PubMed Web of Science ®Google Scholar
• Ehrig, U., Harrison, J. E. & Wilson, D. R. 1974. Effect of long-term thiazide therapy on intestinal calcium absorption in patients with recurrent renal calculi. Metabolism 23, 139.
   PubMed Web of Science ®Google Scholar
• Fleisch, H. 1978. Inhibitors and promoters of stone formation. Kidney Internat 13, 361.
   PubMed Web of Science ®Google Scholar
• Harrison, J. E., Hitchman, A. J. W., Finlay, J. M., Fraser, D., Yendt, E. R., Bayley, T. A. & McNeill, K. G. M. 1971. Effect of treatment on calcium kinetics in metabolic bone disease. Metabolism 20, 1107.
   PubMed Web of Science ®Google Scholar
• Johansson, G. 1979. Magnesium metabolism. Studies in health, primary hyperparathyroidism and renal stone disease. Scand J Urol Nephrol, Suppl. 51, 1.
   Google Scholar
• Johansson, G., Backman, U., Danielson, B. G., Fellström, B., Ljunghall, S. & Wikström, B. 1980. Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol 124, 770.
   PubMed Web of Science ®Google Scholar
• Jörgensen, F. S. 1976. Effects of thiazide diuretics upon calcium metabolism. (Thesis.) Lægeforeningens forlag, Copenhagen.
   Google Scholar
• Jörgensen, F. S., Transböl, I. & Binder, C. 1973. The effect of bendroflumethiazide on total, ultrafiltrable and ionized calcium in serum in normocalcaemic renal stone formers and in hyperparathyroidism. Acta Med Scand 194, 323.
   PubMedGoogle Scholar
• Koppel, M. H., Massry, S. G., Shinaberger, J. H., Hartenbower, D. L. & Coburn, J. W. 1970. Thiazide-induced rise in serum calcium and magnesium in patients on maintenance hemodialysis. Ann Int Med 72, 895.
   PubMed Web of Science ®Google Scholar
• Lamberg, B. A. & Kuhlbäck, B. 1959. Effect of chlorothiazide and hydrochlorothiazide on the excretion of calcium in urine. Scand J Clin Lab Invest 11, 351.
   PubMed Web of Science ®Google Scholar
• Lim, P. & Jacob, E. 1972. Magnesium deficiency in patients on long-term treatment diuretic therapy for congestive heart failure. Br Med J 3, 620.
   PubMed Web of Science ®Google Scholar
• Ljunghall, S., Backman, U., Danielson, B. G., Johansson, G., Jung, B., Källsen, R., Wibell, L. & Wålinder, O. 1977. Mechanisms of hypercalciuria in recurrent renal stone formers. Scand J Urol Nephrol, Suppl. 41, 77.
   Google Scholar
• Ljunghall, S., Backman, U., Danielson, B. G., Fellström, B., Johansson, G. & Wikström, B. 1980. Calcium metabolism in renal stone disease. Scand J Urol Nephrol, Suppl. 53, 111.
   Google Scholar
• Lockefeer, J. H. M., Juttman, J. R. & Birkenhäger, J. C. 1977. The effect of long-term chlorthalidon on stone formation and stone growth, intestinal absorption of calcium and secretion of parathyroid hormone in idiopathic hypercalciuria. Neth J Med 20, 257.
   PubMed Web of Science ®Google Scholar
• Muldowney, F. P., Freaney, R., McMullin, J. P., Towers, R. P., Spillane, A., O'Conner, P., O'Donohoe, P. & Moloney, M. 1976. Serum ionized calcium and parathyroid hormone in renal stone disease. Q J Med 45, 75.
   PubMedGoogle Scholar
• Nordin, B. E. C., Peacock, M. & Wilkinson, R. 1972. Hypercalciuria and calcium stone disease. Clin Endocrinol Metabol 1, 169.
   Google Scholar
• Pak, C. Y. C. 1973. Hydrochlorothiazide therapy in nephrolithiasis. Effect on the urinary activity product and formation products of brushite. Clin Pharm Therap 14, 209.
   PubMed Web of Science ®Google Scholar
• Pak, C. Y. C., Ohata, M., Lawrence, E. C. & Snyder, W. 1974. The hypercalciurias. Causes, parathyroid functions and diagnostic criteria. J Clin Invest 54, 387.
   PubMed Web of Science ®Google Scholar
• Paloyan, E., Forland, M. & Pickleman, J. R. 1969. Hyperparathyroidism coexisting with hypertension and prolonged thiazide administration. JAMA 210, 1243.
   PubMed Web of Science ®Google Scholar
• Pickleman, J. R., Straus II, F. H., Forland, M. & Paloyan, E. 1969. Thiazide-induced parathyroid stimulation. Metabolism 18, 867.
   PubMed Web of Science ®Google Scholar
• Prien, E. L. & Williams, H. E. 1978. Metabolic aspects of renal stone disease. In Contemporary metabolism (ed. N.Freinkel), pp. 181–192. Plenum, New York and London.
   Google Scholar
• Robertson, W. G., Peacock, M. & Heyburn, P. J. 1980. Clinical and metabolic aspects of urinary stone disease in Leeds. Scand J Urol Nephrol, Suppl. 53, 199.
   Google Scholar
• Stote, R. M., Smith, L. H., Wilson, D. M., Dube, W. J., Goldsmith, R. S. & Arnaud, C. D. 1972. Hydrochlorothiazide effects on serum calcium immunoreactive parathyroid hormone concentrations. Studies in normal subjects. Ann Int Med 77, 587.
   PubMed Web of Science ®Google Scholar
• Williams, H. E. & Prien, E. L.Jr, 1977. Nephrolithiasis In Metabolic Bone Disease, vol. I (ed. L. V.Avioli), pp. 387–423. Academic Press, New York, 1977.
   Google Scholar
• Yendt, E. R. & Cohanim, M. 1978. Prevention of calcium stones with thiazides. Kidney Int 13, 397.
   PubMed Web of Science ®Google Scholar
• Yendt, E. R., Gagné, R. K. A. & Cohanim, M. 1966. The effect of thiazides in idiopathic hypercalciuria. Am J Med Sci 251, 449.
   PubMed Web of Science ®Google Scholar
• Zerwekh, J. & Pak, C. Y. C. 1980. Selective effects of thiazide therapy on serum 1,25-dihydroxivitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias. Metabolism 29, 13.
   PubMed Web of Science ®Google Scholar